Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Curevac

Clinical trials sponsored by Curevac, explained in plain language.

Now part of BioNTech SE BNTX NASDAQ

Develops mRNA-based vaccines and therapeutics.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1
Sort by
  • Lung cancer mRNA vaccine trial pulled before it began

    Disease control Terminated

    This early-stage study aimed to test a new mRNA vaccine (CVHNLC) combined with the immunotherapy drug pembrolizumab in people with advanced squamous non-small-cell lung cancer. The trial was designed to find a safe dose and see if the combination could shrink tumors. However, the…

    Phase: PHASE1 • Sponsor: CureVac • Aim: Disease control

    Last updated Jun 27, 2026 13:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space